Shares in MeiraGTx rose after the company said it received positive data in a clinical bridging study of AAV-GAD for the treatment of Parkinson's disease. Shares were up nearly 14% in premarket ...
30, 2024 — Researchers have found a way to better control the preclinical generation of key neurons depleted in Parkinson's disease, pointing toward a new approach for a disease with no cure and few ...
then the symptoms can be treated the same way as Parkinson’s disease, with both non-pharmacologic therapies and the same medicines that are used to treat Parkinson’s. Non-pharmacologic treatments that ...